Company intelligence / Profile preview
Talem Therapeutics
Cambridge, Massachusetts, United Statestalemtherapeutics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Talem’s pipeline consists of next-generation antibody therapeutics in preclinical or lead selection stages. The company has demonstrated proof-of-concept for several bispecific antibodies targeting solid tumors such as triple negative breast cancer by engaging T cells via CD3. It is also developing novel antibodies against vascular targets with preclinical validation of activity. No clinical trial results have been reported yet.
- Therapeutic areas
- OncologyCardiovascularRare DiseasesInfectious Diseases
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugate (ADC)Nanoparticle
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Janssen Research & Development – research license agreement on novel mAbsPierre Fabre – multi-target immuno-oncology research collaborationLibera Bio – AI-driven intracellular delivery of antibodies using MPN nanotechnology
Beyond the preview
Go deeper on Talem Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Talem Therapeutics.